Home Health & Hospice Week

Industry Note:

Pharma Exec New HHS Secretary Nominee

Following Tom Price's resignation as Department of Health & Human Services Secretary, President Trump has nominated ex-pharma exec Alex Azar as the HHS head. Azar spent 10 years at Eli Lilly, but was also HHS general counsel and deputy secretary previously, press reports say. Azar is reportedly critical of the Affordable Care Act and favors converting Medicaid to block grants.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Home Health & Hospice Week

View All